Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q2 2017 · 10-Q
Revenue$210.57K$210.57K−10.8% vs Q2 2016 Net Income-$19.13K-$19.13KN/M vs Q2 2016 EPS Diluted$0.00$0.00— vs Q2 2016 Gross Profit$121,723−0.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flowderived-$7,487N/M Free Cash Flowderived-$29,174N/M Margins · derivedGross margin57.8%+5.9 pt vs Q2 2016
Operating margin-10.3%−5.1 pt vs Q2 2016
Net margin-9.1%−4.1 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 18, 2017 · 49 d after period end